Dec 1, 1998 · Twenty-five patients with CAP who received 750 or l500 mg of cefuroxime per day by CI were compared with 25 patients given 750 mg of cefuroxime three times daily by II
Dizziness and drowsiness may occur less often, especially with higher doses
Cefuroxime sodium contains approximately 54
Sep 11, 2023 · This product is intended for intravenous administration only
Cefuroxime for Injection, USP contains approximately 54
CEFTIN is a cephalosporin antibacterial drug indicated for the treatment of the following infections due to susceptible bacteria: (1) Pharyngitis/tonsillitis (adults and pediatric patients) Acute Cystitis
503 CEFTIN for Oral Suspension: CEFTIN for Oral Suspension is provided as dry, white to 504 off-white, tutti-frutti–flavored powder
A very serious allergic reaction to this drug is rare
Cefuroxime Cefoxitin Ceftriaxone/cefotaxime Cefixime Ceftazidime Ceftolozane-tazobactam Meropenem/imipenem/doripenem Levofloxacin/moxifloxacin Levofloxacin/moxifloxacin
3 months-12 years: 30 mg/kg/day suspension PO divided q12hr for 10 days; not to exceed 1000 mg/day; alternatively, 75-150 mg/kg/day IV/IM divided q8hr; not to exceed 6 g/day
Do not try to extrapolate ceftriaxone susceptibility to predict oral third generation susceptibility
Cefdinir works by binding to
CEFTIN Tablets are film-coated and contain the equivalent of 125, 250, or 500 mg of cefuroxime as cefuroxime axetil
75 g 8 hrly, by deep IM or slow IV inj over 3-5 min or IV infusion, may increase up to 1
Cefuroxime is used for: Pharyngitis, Acute otitis media, Lyme disease, Susceptible infections, Sinusitis, Otitis media, Skin and skin structure infections,Tonsillitis, Respiratory tract infections, Acute Maxillary Sinusitis, Urinary tract infections, Acute bacterial exacerbation of chronic bronchitis, Surgical Prophylaxis Cephalosporins are the largest group of beta-lactam antibiotics, cover a broad range of organisms, are generally well-tolerated, are easy to administer, and are thus frequently used
Side Effects
Cefuroxime axetil tablets are indicated for the treatment of adult patients and pediatric patients (aged 13 and older) with uncomplicated gonorrhea, urethral and endocervical, caused by penicillinase producing and non-penicillinase–producing susceptible strains of Neisseria gonorrhoeae and uncomplicated gonorrhea, rectal, in
Irritation where the shot is given
250 mg twice daily
Rajive Goel 6 May 2010
urinae infection
influenzae, N
aeruginosa therapy include the epidemiology, the patient's risk factors, the site of infection, and the available treatment options
Parenteral Susceptible infections Adult: 0
Some are simple UTIs that can be managed with outpatient antibiotics and carry a reassuring clinical course with an almost universally good outcome
Dose reduction required for CrCl < 30mL/min (same doses but administered every other day)
6 g of cefuroxime axetil equivalent to 3 g of cefuroxime
Intermittent: Intraperitoneal: 15 to 20 mg/kg added to one exchange of dialysis solution once daily (allow to dwell for ≥6 hours)